See every LvlUp fund and program in one place.
Discover our value-focused philosophy and unique venture ecosystem.
The LvlUp Ventures First Check Fund. 1,000 investments in 2026.
Discover LvlUp's unique venture debt / non-dilutive financing fund for B2B startups.
See how we're powering non-dilutive growth for pre-seed to growth-stage startups.
Learn how we're backing the next generation of e-commerce ecosystem technology.
A VC team in your corner for your entire startup journey.
See how we're scaling the future of CPG brands.
Enabling non-dilutive growth for CPG startups.
A high-touch accelerator for founders building scalable consumer brands.
High-conviction capital. Strategic scale.
Supporting brick-and-mortar and service businesses with equity capital and financing.
Supporting brick-and-mortar and services businesses with non-dilutive growth.
Who we are, how we invest and how LvlUp has grown since 2023.
Meet our core, associate, and extended team powering the ecosystem.
Read articles from the LvlUp team, our VCs in residence, and guest contributors.
Learn more about our process and unique offerings for LPs.
Bringing LvlUp's capital, network, and operating infrastructure to Europe, from Paris.
Bringing LvlUp's capital, network, and operating infrastructure to the Middle East, from Dubai.
LvlUp Ventures backs founders from first check to late stage.
Apply for fundingElixion Biotech develops first-in-class oncology assets by targeting causal disease drivers. We have in silico validated two targets (one novel, high-upside) and are advancing towards confirmation alongside in silico drug design, positioning for early partnering in high-need cancers.
